FDA Approves Continuous Glucose Monitor for Children
The FDA has expanded the approval of the Dexcom G4 Platinum continuous glucose monitoring (CGM) system to include use for children aged 2 to 17 years of age despite reduced accuracy compared with adults.
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.